Referanslar

• Albayrak, A., Başgut, B., Bıkmaz, G, A., & Karahalil, B. (2022). Clin-ical pharmacist assessment of drug-related problems among inten-sive care unit patients in a Turkish university hospital. BMC Health ServiceResearch, 22(1), 1-7. https://doi.org/10.1186/s12913-022-07494-5 google scholar
• Aljbouri, T. M., Alkhawaldeh, M. S., Abu-Rumman, K.,Hasan, T. A., Khattar, H. M., & Abu- Oliem, A. S. (2013). Im-pact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharmaceutical Journal, 21(4), 371-374. https://doi.org/10.1016/j.jsps.2012.12.004 google scholar
• Al-azzam, S. I., Shara, M., Alzoubi, K. H., Almahasneh, F. A., & Iflaifel, M. H. (2013). Implementation of clinical phar-macy services at a university hospital in Jordan. The In-ternational Journal of Pharmacy Practice, 21(5), 337-340. https://doi.org/10.1111/ypp.12009 google scholar
• Al-Jazairi, A. S., Al-Agil, A. A., Asiri, Y. A.,Al-Kholi, T. A., Akhras, N. S., & Horanieh, B. K. (2008).The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Medical Journal, 29(2), 277-81. google scholar
• Ayhan, Y. E., Karakurt, S., & Sancar, M. (2022). The effect of the clinical pharmacist in minimizing drug-related problems and re-lated costs in the intensive care unit in Turkey: A non- randomized controlled study. Journal of Clinical Pharmacy and Therapeutics, 47(11), 1867- 1874. https://doi.org/10.1111/jcpt.13784 google scholar
• Bourne, R. S., Choo, C. L., & Dorward, B. J. (2014). Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors. The International Journal of Pharmacy Prac-tice, 22(2), 146-154. https://doi.org/10.1111/ypp.12046 google scholar
• Clemmons, A. (2020). The Hematopoietic Cell Transplant Pharmacist: A Call to Action. Pharmacy, 8(1), 1-7. https://doi.org/10.3390/pharmacy8010003 google scholar
• Greeshma, M., Lincy, S., Maheswari, E., Tharanath, S., & Viswam, S. (2018). Identification of drug related problems by clinical phar-macist in prescriptions with polypharmacy: A prospective inter-ventional study. Journal of Young Pharmacists, 10(4), 460-465. https://doi.org/10.5530/jyp.2018.10.100 google scholar
• Horvat, N., & Kos, M. (2016). Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2. International Journal of Clinical Pharmacy, 38(4), 950-959. https://doi.org/10.1007/s11096-016-0320-7 google scholar
• Jiang, S-P., Chen, J., Zhang, X-G., Lu, X-Y., & Zhao, Q-W. (2014). Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Therapeutics and Clinical Risk Management, 10, 861866. https://doi.org/10.2147/TCRM.S69585 google scholar
• Johansen, E. T., Haustreis, S. M., Mowinckel, A. S., & Ytreb0, L. M. (2016). Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU. European Journal of Hospital Pharmacy, 23(4), 197-202. https://doi.org/10.1136/ejhpharm-2015-000751 google scholar
• Kubas, M. A., & Halboup, A. M. (2020). Implementation of clinical pharmacist recommendations and services at a University Hospital in Yemen. International Journal of Clinical Pharmacy, 42(1), 5156. https://doi.org/10.1007/s11096-019-00936-x google scholar
• Kaufmann, C. P., Stampfli, D., Hersberger, K. E., &Lampert, M. L. (2015). Determination of risk factors for drug-related problems: A multidisciplinary triangulation process. BMJ Open,5(3), e006376-82. https://doi.org/10.1136/bmjopen-2014-006376 google scholar
• Lee, H., Ryu, K., Sohn, Y.,Kim, J., Suh, G. Y., &Kim, E. Y. (2019). Impact on patient outcomes of pharmacist participa-tion in multidisciplinary critical care teams: A systematic review and meta-analysis. Critical Care Medicine, 47(9), 1243-1250. https://doi.org/10.1097/CCM.0000000000003830 google scholar
• Lenssen, R., Heidenreich, A., Schulz, J. B., Trautwein, C., Fitzner, C., Jaehde, U., & Eisert, A. (2016). Analysis of drug-related problems in three departments of a German University hospi-tal. International Journal of Clinical Pharmacy, 38(1), 119-126. https://doi.org/10.1007/s11096-015-0213-1 google scholar
• Li, X-x., Zheng, S-q., Gu, J-h., Huang, T., Liu, F., Ge, Q-g., . . . Shi, L-w. (2020). Drug-related problems identified during pharmacy intervention and consultation: Implementation of an intensive care unit pharmaceutical care model. Frontiers in Pharmacology. 11, 1-13 (571906). https://doi.org/10.3389/fphar.2020.571906 google scholar
• Martins, R. R., Silva, L. T., & Lopes, F. M. (2019). Impact of medica-tion therapy management on pharmacotherapy safety in an inten-sive care unit. International Journal of Clinical Pharmacy, 41(1), 179-188. https://doi.org/10.1007/s11096-018-0763-0 google scholar
• Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(230), 1-10. https://doi.org/10.1186/s12877-017-0621-2 google scholar
• Napier, K., Lim, D., Thomas, E., Boyd, J., Chakera, A., Williamson, J., . . . Robinson, S. (2022). Impact of routine reporting of estimated glomerularfiltration rate using the European Kidney Function Consortium and Chronic Kidney Disease Epidemiology Collabo-ration equations in a Western Australian community population. Nephrology, 27(10), 823-833. https://doi.org/10.1111/nep.14083 google scholar
• Ozdemir, N., Celiker, A., Kuskonmaz, B. B., Okur, F. V., & Cetinkaya, D. U. (2019). Evaluation of Drug-Related Prob-lems in a Pediatric Bone Marrow Transplantation Unit Iden-tified by a Clinical Pharmacist in-training in a 7-Month Pe-riod. Clinical and Experimental Health Sciences, 10(1), 21-26. https://doi.org/10.33808/clinexphealthsci.590213 google scholar
• Pharmaceutical Care Network Europe Asso-ciation. (20.04.2023). Accessed address: https://www.pcne.org/upload/files/410_PCNE_classification_V9-0m.pdf. google scholar
• Reinau, D., Furrer, C., Stampfli, D.,Bornand, D., & Meier, C. R. (2019). Evaluation of drug- related problems and subsequent clinical pharmacists’ interventions at a Swiss university hospital. Journal of Clinical Pharmacy and Therapeutics, 44(6), 924-931. https://doi.org/10.1111/jcpt.13017 google scholar
• Ritchie, L. A., Penson, P. E., Akpan, A. A., Lip, G. Y. H., & Lane, D. A. (2022) Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist. The American Journal of Medicine, 135(12), 1410-1426. https://doi.org/10.1016/j.amjmed.2022.07.014 google scholar
• Ruths, S., Viktil, K. K., &Blix, H. S. (2007). Classification of drug-related problems. The Journal of the Norwegian Medical Associ-ation,127, 3073-3076. google scholar
• Tasaka, Y., Tanaka, A., Yasunaga, D.,Asakawa, T., Araki, H., &Tanaka, M. (2018). Potential drug-related problems detected by routine pharmaceutical interventions: Safety and economic contributions made by hospital pharmacists in Japan. Jour-nal of Pharmaceutical Health Care and Sciences, 4(33), 1-11. https://doi.org/10.1186/s40780-018-0125-z google scholar
• Tharanon, V., Putthipokin, K., &Sakthong, P. (2022). Drug-related problems identified during pharmaceutical care interventions in an intensive care unit at a tertiary university hospital. SAGE Open Medicine, 10, 1-10. https://doi.org/10.1177/20503121221090881 google scholar
• Toukhy, A., Fayed, S., Sabry, N., & Shawki M. (2021). The Impact of an Established Pharmaceutical Care Pathway on Drug Related Problems in an Intensive Care Unit. The American Journal of Medical Sciences, 362(2), 143-153. https://doi.org/10.1016/j.amjms.2021.03.007 google scholar
• Viktil, K. K., & Blix, H. S. (2008). The impact of clinical phar-macists on drug-related problems and clinical outcomes. Ba-sic & Clinical Pharmacology & Toxicology,102(3), 275-280. https://doi.org/10.1111/j.1742-7843.2007.00206.x google scholar
• Zaidi, S. T. R., Hassan, Y., Postma, M. J., & Seiw Hain, N. (2003). Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharmacy World and Science, 25(6), 299-302. https://doi.org/10.1023/B:PHAR.0000006524.52076.2f google scholar

Atıflar